Publication | Closed Access

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseBlood PlateletAtherosclerosisHematologyClinical TrialsCoronary InterventionClinical RestenosisPlatelet Iib/iiia IritegrinAcute Myocardial InfarctionPlatelet AntagonistMedicineAnticoagulantCardiologyEmergency MedicineCoronary Artery DiseaseHealth Sciences